Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer procoagulant--CP

M Rucińska1, M Gacko, Z Skrzydlewski

  • 1Department of Oncology, Medical Academy of Białystok.

Roczniki Akademii Medycznej W Bialymstoku (1995)
|January 1, 1997
PubMed
Summary

Cancer procoagulant (CP) directly activates factor X, a key step in blood clotting. This review explores CP

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer related information that cancer patients need.

Scientific reports·2025
Same author

Health care system and patient-related factors affecting low cancer screening participation in Poland.

Preventive medicine reports·2023
Same author

Conservation and storage of a haploid cucumber (Cucumis sativus L.) collection under in vitro conditions.

Plant cell reports·2019
Same author

Prospective Assessment of Hepcidin in Relation to Delayed or Immediate Graft Function in Patients Undergoing Kidney Transplantation.

Transplantation proceedings·2016
Same author

Diet and the content of selenium and lead in patients with abdominal aortic aneurysm.

VASA. Zeitschrift fur Gefasskrankheiten·2011
Same author

Renal parenchyma perfusion spectrum and resistive index (RI) in ultrasound examinations with contrast medium in the early period after kidney transplantation.

Transplantation proceedings·2009

Area of Science:

  • Biochemistry
  • Oncology
  • Hematology

Background:

  • Cancer procoagulant (CP) is a known activator of the coagulation cascade.
  • Its role in cancer pathogenesis is an area of ongoing research.

Purpose of the Study:

  • To review existing literature on cancer procoagulant (CP).
  • To discuss the potential diagnostic and prognostic applications of CP in cancer.

Main Methods:

  • Literature review of studies on cancer procoagulant.
  • Analysis of CP's mechanism in activating coagulation factor X.

Main Results:

  • Cancer procoagulant (CP) directly activates coagulation factor X to factor Xa.
  • Evidence suggests CP's involvement in cancer-associated thrombosis.

Conclusions:

  • CP's procoagulant activity presents potential for cancer diagnostics.
  • Further research is needed to validate CP as a prognostic biomarker for cancer.